» Articles » PMID: 32469227

Contribution of Selected Vasoactive Systems to Blood Pressure Regulation in Two Models of Chronic Kidney Disease

Overview
Journal Physiol Res
Specialty Physiology
Date 2020 May 30
PMID 32469227
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

It is generally accepted that angiotensin II plays an important role in high blood pressure (BP) development in both 2-kidney-1-clip (2K1C) Goldblatt hypertension and in partial nephrectomy (NX) model of chronic kidney disease (CKD). The contribution of sympathetic nervous system and nitric oxide to BP control in these models is less clear. Partial nephrectomy or stenosis of the renal artery was performed in adult (10-week-old) male hypertensive heterozygous Ren-2 transgenic rats (TGR) and normotensive control Hannover Sprague Dawley (HanSD) rats and in Wistar rats. One and four weeks after the surgery, basal blood pressure (BP) and acute BP responses to the consecutive blockade of renin-angiotensin (RAS), sympathetic nervous (SNS), and nitric oxide (NO) systems were determined in conscious rats. Both surgical procedures increased plasma urea, a marker of renal damage; the effect being more pronounced following partial nephrectomy in hypertensive TGR than in normotensive HanSD rats with a substantially smaller effect in Wistar rats after renal artery stenosis. We demonstrated that the renin-angiotensin system does not play so fundamental role in blood pressure maintenance during hypertension development in either CKD model. By contrast, a more important role is exerted by the sympathetic nervous system, the activity of which is increased in hypertensive TGR-NX in the developmental phase of hypertension, while in HanSD-NX or Wistar-2K1C it is postponed to the established phase. The contribution of the vasoconstrictor systems (RAS and SNS) was increased following hypertension induction. The role of NO-dependent vasodilation was unchanged in 5/6 NX HanSD and in 2K1C Wistar rats, while it gradually decreased in 5/6 NX TGR rats.

Citing Articles

Gliflozins in the Treatment of Non-diabetic Experimental Cardiovascular Diseases.

Vaneckova I, Zicha J Physiol Res. 2024; 73(Suppl 1):S377-S387.

PMID: 38634653 PMC: 11412360. DOI: 10.33549/physiolres.935364.


Sodium thiosulfate through preserving mitochondrial dynamics ameliorates oxidative stress induced renal apoptosis and ferroptosis in 5/6 nephrectomized rats with chronic kidney diseases.

Cheng Y, Yao C, Yang C, Hsu S, Chien C PLoS One. 2023; 18(2):e0277652.

PMID: 36795670 PMC: 9934356. DOI: 10.1371/journal.pone.0277652.


Empagliflozin Is Not Renoprotective in Non-Diabetic Rat Models of Chronic Kidney Disease.

Hojna S, Kotsaridou Z, Vanourkova Z, Rauchova H, Behuliak M, Kujal P Biomedicines. 2022; 10(10).

PMID: 36289772 PMC: 9599022. DOI: 10.3390/biomedicines10102509.


Chronic Kidney Disease: Role of Diet for a Reduction in the Severity of the Disease.

Naber T, Purohit S Nutrients. 2021; 13(9).

PMID: 34579153 PMC: 8467342. DOI: 10.3390/nu13093277.


The organ-specific nitric oxide synthase activity in the interaction with sympathetic nerve activity: a hypothesis.

Liskova S Physiol Res. 2021; 70(2):169-175.

PMID: 33992046 PMC: 8820569. DOI: 10.33549/physiolres.934676.


References
1.
Walkowska A, Skaroupkova P, Huskova Z, Vanourkova Z, certikova Chabova V, Tesar V . Intrarenal cytochrome P-450 metabolites of arachidonic acid in the regulation of the nonclipped kidney function in two-kidney, one-clip Goldblatt hypertensive rats. J Hypertens. 2009; 28(3):582-93. PMC: 2855337. DOI: 10.1097/HJH.0b013e328334dfd4. View

2.
Brooks D, Short B, Cyronak M, Contino L, DiCristo M, Wang Y . Comparison between carvedilol and captopril in rats with partial ablation-induced chronic renal failure. Br J Pharmacol. 1993; 109(2):581-6. PMC: 2175699. DOI: 10.1111/j.1476-5381.1993.tb13610.x. View

3.
Kujal P, certikova Chabova V, Skaroupkova P, Huskova Z, Vernerova Z, Kramer H . Inhibition of soluble epoxide hydrolase is renoprotective in 5/6 nephrectomized Ren-2 transgenic hypertensive rats. Clin Exp Pharmacol Physiol. 2014; 41(3):227-37. PMC: 4038339. DOI: 10.1111/1440-1681.12204. View

4.
Campese V, Kogosov E, Koss M . Renal afferent denervation prevents the progression of renal disease in the renal ablation model of chronic renal failure in the rat. Am J Kidney Dis. 1995; 26(5):861-5. DOI: 10.1016/0272-6386(95)90456-5. View

5.
Guan S, Fox J, Mitchell K, Navar L . Angiotensin and angiotensin converting enzyme tissue levels in two-kidney, one clip hypertensive rats. Hypertension. 1992; 20(6):763-7. DOI: 10.1161/01.hyp.20.6.763. View